Two-Year Follow-up Study of Membranous Nephropathy Treated With Tacrolimus and Corticosteroids Versus Cyclical Corticosteroids and Cyclophosphamide

Two-Year Follow-up Study of Membranous Nephropathy Treated With Tacrolimus and Corticosteroids Versus Cyclical Corticosteroids and Cyclophosphamide

Both cCTX/GCs and CNIs are recommended as first-line agents in the management of PMN. The present study is an extended report of patients randomized to receive TAC/GCs or cCTX/GCs at 2 years post randomization. Methods: Seventy patients enrolled in the clinical trial Tacrolimus Combined With Cortico...

Full description

Bibliographic Details
Main Authors: Raja Ramachandran, Ashok Kumar Yadav, Vinod Kumar, Venkata Siva Tez Pinnamaneni, Ritambhra Nada, Ratan Ghosh, Vivek Kumar, Manish Rathi, Harbir Singh Kohli, Krishan Lal Gupta, Vinay Sakhuja, Vivekanand Jha
Format: Article
Language:English
Published: Elsevier 2017-07-01
Series:Kidney International Reports
Subjects:
cyclophosphamide
membranous nephropathy
PLA2R
randomized control trial
steroids
tacrolimus
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024917300219

Internet

http://www.sciencedirect.com/science/article/pii/S2468024917300219

Similar Items